Titan Pharmaceuticals. Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura. More About Titan Pharmaceuticals Get The Stocktwits Daily Rip 12/30/2019 · Titan Pharmaceuticals, Inc. Common Stock (TTNP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Stock quote and company snapshot for TITAN PHARMACEUTICALS INC (TTNP), including profile, stock chart, recent news and events, analyst opinions, and research reports. 12/31/2019 · TTNP on StockCharts.com Titan Pharmaceuticals, Inc., a specialty pharmaceutical company, develops proprietary therapeutics for the treatment of serious medical disorders in the United States. The company is developing Probuphine for the long term maintenance treatment of opioid dependence. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that 12/30/2018 · See Titan Pharmaceuticals, Inc. (TTNP) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. 1/1/2020 · Get the latest Titan Pharmaceuticals, Inc. (TTNP) stock news and headlines to help you in your trading and investing decisions. Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. In depth view into TTNP (Titan Pharmaceuticals) stock including the latest price, news, dividend history, earnings information and financials.

ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

TTNP – analyst ratings, historical stock prices, earnings estimates & actuals for Titan Pharmaceuticals Inc.. Updated stock price target summary. Stocktoberfest is our annual premier investing event, held in both San Diego and New York City. Sign up to get your ticket, learn about activities, meet the speakers Titan Pharmaceuticals Inc. annual stock financials by MarketWatch. View the latest TTNP financial statements, income statements and financial ratios. "StockInvest.us" is a research service that provides financial data and technical analysis on stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "StockInvest.us". Titan Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. TTNP updated stock price target summary. Titan Pharmaceuticals (NASDAQ:TTNP) Earnings Information. Titan Pharmaceuticals last announced its quarterly earnings data on November 14th, 2019. The specialty pharmaceutical company reported ($0.18) EPS for the quarter, beating analysts' consensus estimates of ($0.21) by $0.03.

View Titan Pharmaceuticals, Inc. TTNP investment & stock information. Get the latest Titan Pharmaceuticals, Inc. TTNP detailed stock quotes, stock data, Real-Time ECN

You are being redirected.

All SEC Filings Filter Filings: View All 10-12G 10-12G/A 10-K 10-K/A 10-K405 10-Q 10-Q/A 10KSB40 10QSB 15-12B 25 3 3/A 4 4/A 424B3 424B4 424B5 8-A12B 8-A12B/A 8-A12G 8-K 8-K/A ARS AW CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DEFR14A EFFECT FWP NT 10-Q POS AM PRE 14A REGDEX S-1 S-1/A S-1MEF S-3 S-3/A S-8 SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A UPLOAD

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Get the detailed quarterly/annual income statement for Titan Pharmaceuticals, Inc. (TTNP). Find out the revenue, expenses and profit or loss over the last fiscal year. Learn how to trade big board and penny stocks by learning to read stock charts and identify technical patterns through technical analysis. Follow along and learn as I perform a quick stock chart technical analysis review on the Titan Pharmaceuticals Inc (TTNP) chart. Stock quote and company snapshot for NUGL INC (NUGL), including profile, stock chart, recent news and events, analyst opinions, and research reports.

Market data provided by Xignite, Inc. and ICE Data Services. Commodity and historical index data provided by Pinnacle Data Corporation. Unless otherwise indicated

27 Nov 2019 Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares shot up 6.7% during mid-day trading on Wednesday . The stock traded as high as $0.17  17 Jun 2019 Dec 13, 2019 · ST Invest is a wholly owned subsidiary of StockTwits, Inc. Titan Pharmaceuticals (TTNP) As Probuphine Success Continues,  Real-time trade and investing ideas on Titan Pharmaceuticals Inc. TTNP from the largest community of traders and investors. Real-time trade and investing ideas on Tonix Pharmaceuticals Holding Corp TNXP from the largest community of traders and investors.

Real-time trade and investing ideas on Tonix Pharmaceuticals Holding Corp TNXP from the largest community of traders and investors.